Cargando…

Gut bacterial profiles in Parkinson's disease: A systematic review

INTRODUCTION: Recent advances have highlighted the relationships between gut dysbiosis and Parkinson's disease (PD). Microbiota transplantation from PD patients to mice can induce increased alpha‐synuclein‐mediated motor deficits. Human studies have identified differences in the gut microbiota...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhe, Liang, Hongfeng, Hu, Yingyu, Lu, Lin, Zheng, Chunye, Fan, Yuzhen, Wu, Bin, Zou, Tao, Luo, Xiaodong, Zhang, Xinchun, Zeng, Yan, Liu, Ziyan, Zhou, Zhicheng, Yue, Zhenyu, Ren, Yi, Li, Zhuo, Su, Qiaozhen, Xu, Pingyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804059/ https://www.ncbi.nlm.nih.gov/pubmed/36284437 http://dx.doi.org/10.1111/cns.13990

Ejemplares similares

Altered Actinobacteria and Firmicutes Phylum Associated Epitopes in Patients With Parkinson’s Disease
por: Li, Zhuo, et al.
Publicado: (2021)

Reduced regional activity and functional connectivity within sensorimotor network in Parkinson’s patients with restless legs syndrome
por: Li, Zhe, et al.
Publicado: (2019)

Acupuncture Modulates the Cerebello-Thalamo-Cortical Circuit and Cognitive Brain Regions in Patients of Parkinson's Disease With Tremor
por: Li, Zhe, et al.
Publicado: (2018)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
por: Li, Puyu, et al.
Publicado: (2021)

Cortical Synaptic Mechanism for Chronic Pain and Anxiety in Parkinson’s Disease
por: Zhou, Zhaoxiang, et al.
Publicado: (2023)

Effects of levodopa on gut bacterial antibiotic resistance in Parkinson’s disease rat
por: Sheng, Shuo, et al.
Publicado: (2023)

Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2020)

Metaproteomics as a tool for studying the protein landscape of human-gut bacterial species
por: Stamboulian, Moses, et al.
Publicado: (2022)

Consistency and Stability of Motor Subtype Classifications in Patients With de novo Parkinson’s Disease
por: Ren, Jingru, et al.
Publicado: (2021)

Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2019)

Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson’s Disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2019)

Altered gut bacterial–fungal interkingdom networks in patients with current depressive episode
por: Jiang, Hai‐yin, et al.
Publicado: (2020)

Comparison of Three Motor Subtype Classifications in de novo Parkinson's Disease Patients
por: Ren, Jingru, et al.
Publicado: (2020)

Serotonin modulates insect gut bacterial community homeostasis
por: Zeng, Tian, et al.
Publicado: (2022)

Consideration of Gut Microbiome in Murine Models of Diseases
por: Zhang, Chunye, et al.
Publicado: (2021)

Looking into key bacterial proteins involved in gut dysbiosis
por: Zeng, Xin-Yu, et al.
Publicado: (2021)

The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer
por: Zhang, Chunye, et al.
Publicado: (2020)

Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson's Disease
por: Zhang, Yunlong, et al.
Publicado: (2016)

Honokiol Suppresses Renal Cancer Cells’ Metastasis via Dual-Blocking Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties through Modulating miR-141/ZEB2 Signaling
por: Li, Weidong, et al.
Publicado: (2014)

Alterations of gut viral signals in atrial fibrillation: complex linkage with gut bacteriome
por: Zuo, Kun, et al.
Publicado: (2022)

Characterizing mild cognitive impairment in prodromal Parkinson’s disease: A community‐based study in China
por: Pan, Chenxi, et al.
Publicado: (2021)

Wnt1 Promotes EAAT2 Expression and Mediates the Protective Effects of Astrocytes on Dopaminergic Cells in Parkinson's Disease
por: Wei, Lei, et al.
Publicado: (2019)

The biomarkers of immune dysregulation and inflammation response in Parkinson disease
por: Chen, Li, et al.
Publicado: (2016)

Non-Motor Symptoms of the Postural Instability and Gait Difficulty Subtype in De Novo Parkinson’s Disease Patients: A Cross-Sectional Study in a Single Center
por: Ren, Jingru, et al.
Publicado: (2020)

Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease
por: Chen, Qian-Qian, et al.
Publicado: (2019)

Prevalence and genotype–phenotype correlations of GBA‐related Parkinson disease in a large Chinese cohort
por: Ren, Jingru, et al.
Publicado: (2022)

Meta-Analysis of the Relationship between the APOE Gene and the Onset of Parkinson's Disease Dementia
por: Pang, Suisui, et al.
Publicado: (2018)

Stent drainage achieved by endoscopic ultrasonography-guided puncture from duodenal bulb to the minor pancreatic duct for the treatment of acute epigastric pain in a patient with pancreas divisum
por: Cheng, Bin, et al.
Publicado: (2018)

5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis
por: Xu, Jun, et al.
Publicado: (2018)

A Novel Major Facilitator Superfamily Transporter Gene Aokap4 near the Kojic Acid Gene Cluster Is Involved in Growth and Kojic Acid Production in Aspergillus oryzae
por: Chen, Tianming, et al.
Publicado: (2022)

Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson’s disease by regulating gut microbiota
por: Zhang, Yi, et al.
Publicado: (2023)

Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome
por: Li, Xue, et al.
Publicado: (2023)

Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2021)

Gut Feelings on Parkinson’s and Depression
por: Dinan, Timothy G., et al.
Publicado: (2017)

The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease
por: Yang, Dongming, et al.
Publicado: (2019)

Potential Therapeutic Drugs for Parkinson's Disease Based on Data Mining and Bioinformatics Analysis
por: Xu, Chuan, et al.
Publicado: (2018)

Sleep Disturbances and Associated Factors in Drug-Naïve Patients with Parkinson’s Disease
por: Zhong, Min, et al.
Publicado: (2021)

Analysis of the Gut Microflora in Patients With Parkinson's Disease
por: Jin, Miao, et al.
Publicado: (2019)

Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
por: Tang, Yuting, et al.
Publicado: (2023)

The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson’s disease
por: Li, Qing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g0ahuimh9hals1gop1r7unjf69